New Life Sciences Fund and leadership churn reveal continued reset at BDC
Growth Venture Fund leader is out nine months after BDC allocates $1 billion and expands mandate.
Growth Venture Fund leader is out nine months after BDC allocates $1 billion and expands mandate.
UBC spinout aims to conquer blood-brain barrier to improve protein delivery to the brain.
Collaboration aims to build AI systems capable of biological inference and experimental assay prediction.
CVCA says rise in growth investment “a good sign” but early-stage VC activity continues to lag.
Virtual care provider buys New Brunswick platform to improve ADHD offerings.
OutreachGenius, Happly.AI among winners taking home more money than ever before.
Healthtech startup’s app turns smartphones into a Health Canada-approved stethoscope.
Fund will support immigrants building early-stage AgTech, food tech, and healthtech startups.
Together, 2025 winners averaged a three-year revenue growth of 2,623 percent.
Newly profitable Toronto startup aims to scale operations before generic weight loss drugs arrive in Canada.
The Vancouver impact fund has already invested $2 million across eight Canadian startups.
Series D funding will support commercialization of Halifax company’s Eye90 microspheres.
Vancouver-based studio’s inaugural fund is fetching $10 million to help build pet health startups.
Calgary-based Corbett joins a month after Isaac Souweine left the fund.
Entrepreneurs say slow policy and weak procurement limit Canadians’ access to aging and fertility tech.